Artelo Biosciences Inc.

NASDAQ: ARTLW · Real-Time Price · USD
0.01
0.00 (78.57%)
At close: Jun 17, 2024, 10:00 PM

Artelo Biosciences Balance Sheet Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Nov 30, 2021 Aug 31, 2021 May 31, 2021 Feb 28, 2021
Cash & Equivalents
2.64M 5.72M 6.92M 6.89M 7.14M 12.12M 10.35M 12.16M 6.63M 10.05M 10.71M
Short-Term Investments
10.22M 8.27M 8.57M 10.64M 12.35M 9.2M 13.16M 11.95M 3.44M n/a 512.03K
Long-Term Investments
n/a n/a n/a -1.5M -1.49M -1.99M n/a 1.52M n/a n/a n/a
Other Long-Term Assets
-0.00 197K 3K 3K 3K 3K 3K 3K 189K n/a n/a
Receivables
n/a n/a n/a n/a n/a n/a 2M n/a n/a n/a n/a
Inventory
n/a n/a n/a n/a n/a n/a -4M n/a n/a n/a n/a
Other Current Assets
10.79M 611K 903K 789K 2.31M 2.95M 3.08M 514K 252K 248K 186.74K
Total Current Assets
13.43M 14.6M 16.39M 18.32M 20.3M 22.28M 24.59M 24.61M 10.32M 10.3M 11.41M
Property-Plant & Equipment
29K 39K 50K 60K 70K 81K 73K 81K 90K 63.00 124.00
Goodwill & Intangibles
2.04M 2.04M 2.04M 2.04M 2.04M 2.04M 2.04M 2.04M 2.04M 2.04M 2.04M
Total Long-Term Assets
2.07M 2.27M 2.09M 2.1M 2.11M 2.12M 2.12M 3.64M 2.32M 2.04M 2.04M
Total Assets
15.5M 16.88M 18.48M 20.42M 22.41M 24.41M 26.7M 28.25M 12.63M 12.34M 13.44M
Account Payables
840K 523K 701K 905K 411K 432K 800K 975K 493K 418.94K 583.97K
Deferred Revenue
-32K -523K n/a n/a n/a n/a n/a n/a n/a n/a n/a
Short-Term Debt
32K 34K 37K 40K 42K 45K 32K 31K 28K n/a n/a
Other Current Liabilities
49K 569K 87K 53K 27K 50K 43K 21K 5K 5K 5K
Total Current Liabilities
921K 603K 825K 998K 480K 527K 875K 1.03M 526K 423.94K 588.97K
Long-Term Debt
n/a 6K 15K 23K 32K 40K 49K 57K 67K n/a n/a
Other Long-Term Liabilities
n/a n/a n/a n/a n/a n/a n/a n/a n/a 418.94K 583.97K
Total Long-Term Liabilities
n/a 6K 15K 23K 32K 40K 49K 57K 67K 418.94K 583.97K
Total Liabilities
921K 609K 840K 1.02M 512K 567K 924K 1.08M 593K 423.94K 588.97K
Total Debt
32K 40K 52K 63K 74K 85K 81K 88K 95K n/a n/a
Book Value
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Book Value Per Share
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock
3K 3K 3K 3K 3K 42K 42K 42K 25K 23.15K 22.21K
Retained Earnings
-37.24M -34.79M -33.19M -31.02M -27.68M -25.35M -22.9M -20.94M -16.9M -15.02M -12.77M
Comprehensive Income
-199K -201K -205K -254K -388K -176K -64K -18K 18K 49.38K 47.9K
Shareholders Equity
14.58M 16.27M 17.64M 19.4M 21.9M 23.84M 25.78M 27.17M 12.04M 11.92M 12.86M
Total Investments
10.22M 8.27M 8.57M 9.15M 10.86M 7.21M 13.16M 12.32M 3.44M n/a 512.03K